| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ADH1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2044 | 6480464 | Ethinyl Estradiol results in decreased expression of ADH1 mRNA | CTD | PMID:15953391 PMID:17108234 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADH1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2044 | 6480464 | Ethinyl Estradiol results in decreased expression of ADH1 mRNA | CTD | PMID:17108234 PMID:15953391 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of ADH1 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | decreases expression | ISO | RGD:1344246 | 6480464 | Estradiol results in decreased expression of ADH1C mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ADH1 mRNA | CTD | PMID:14664709 |
| 1H-pyrazole | decreases activity | ISO | RGD:2044 | 6480464 | pyrazole results in decreased activity of ADH1 protein | CTD | PMID:15551062 |
| 1H-pyrazole | multiple interactions | EXP | | 6480464 | pyrazole inhibits the reaction [ADH1 protein results in increased metabolism of Ethanol] | CTD | PMID:7646056 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADH1 mRNA | CTD | PMID:17949056 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADH1 mRNA | CTD | PMID:17949056 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1344246 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADH1C mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2044 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADH1 mRNA | CTD | PMID:18796159 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1344246 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADH1C mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2044 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADH1 mRNA | CTD | PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADH1 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2044 | 6480464 | 2,4-dinitrotoluene affects the expression of ADH1 mRNA | CTD | PMID:21346803 |
| 2-butoxyethanol | decreases expression | EXP | | 6480464 | n-butoxyethanol results in decreased expression of ADH1 mRNA | CTD | PMID:19812364 |
| acetaldehyde | increases chemical synthesis | EXP | | 6480464 | ADH1 protein results in increased chemical synthesis of Acetaldehyde | CTD | PMID:11893554 |
| acetaldehyde | multiple interactions | ISO | RGD:1344246 | 6480464 | [ADH1C protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde | CTD | PMID:15138216 |
| acetaldehyde | multiple interactions | EXP | | 6480464 | [ADH1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde; more ... | CTD | PMID:7646056 |
| acrolein | affects reduction | ISO | RGD:2044 | 6480464 | ADH1 protein affects the reduction of Acrolein | CTD | PMID:12604195 |
| aflatoxin B1 | affects expression | ISO | RGD:1344246 | 6480464 | Aflatoxin B1 affects the expression of ADH1C protein | CTD | PMID:20106945 |
| alpha-hexachlorocyclohexane | decreases expression | ISO | RGD:2044 | 6480464 | alpha-hexachlorocyclohexane results in decreased expression of ADH1 mRNA | CTD | PMID:16940010 |
| Aroclor 1254 | decreases expression | ISO | RGD:2044 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of ADH1 mRNA | CTD | PMID:18178546 |
| benzene | affects expression | ISO | RGD:2044 | 6480464 | Benzene affects the expression of ADH1 mRNA | CTD | PMID:15878777 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ADH1 mRNA | CTD | PMID:22228805 |
| bisphenol A | decreases expression | ISO | RGD:2044 | 6480464 | bisphenol A results in decreased expression of ADH1C mRNA | CTD | PMID:22842222 |
| cisplatin | increases expression | ISO | RGD:2044 | 6480464 | Cisplatin results in increased expression of ADH1 protein | CTD | PMID:22023808 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ADH1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | ISO | RGD:2044 | 6480464 | Clofibrate results in increased expression of ADH1 mRNA | CTD | PMID:12851107 |
| clofibric acid | multiple interactions | ISO | RGD:2044 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADH1 mRNA | CTD | PMID:17602206 |
| copper atom | decreases expression | ISO | RGD:2044 | 6480464 | Copper results in decreased expression of ADH1 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | ISO | RGD:2044 | 6480464 | Copper results in decreased expression of ADH1 mRNA | CTD | PMID:22465980 |
| cyanamide | multiple interactions | EXP | | 6480464 | Cyanamide promotes the reaction [[ADH1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde] | CTD | PMID:7646056 |
| cyclosporin A | decreases expression | ISO | RGD:1344246 | 6480464 | Cyclosporine results in decreased expression of ADH1C mRNA | CTD | PMID:20106945 |
| dexamethasone | increases expression | ISO | RGD:2044 | 6480464 | Dexamethasone results in increased expression of ADH1 mRNA | CTD | PMID:20032058 |
| dexamethasone | multiple interactions | ISO | RGD:2044 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of ADH1 mRNA] | CTD | PMID:20032058 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADH1 mRNA | CTD | PMID:20003209 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of ADH1 mRNA | CTD | PMID:15171707 |
| dioxygen | decreases expression | ISO | RGD:1344246 | 6480464 | Oxygen deficiency results in decreased expression of ADH1C mRNA | CTD | PMID:19695866 |
| disulfiram | decreases activity | ISO | RGD:2044 | 6480464 | Disulfiram results in decreased activity of ADH1 protein | CTD | PMID:15551062 |
| ethanol | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Ethanol] results in increased expression of ADH1 mRNA | CTD | PMID:19637192 |
| ethanol | increases expression | ISO | RGD:1344246 | 6480464 | Ethanol results in increased expression of ADH1C mRNA | CTD | PMID:23300006 |
| ethanol | affects response to substance | ISO | RGD:1344246 | 6480464 | ADH1C gene polymorphism affects the susceptibility to Ethanol | CTD | PMID:20171022 |
| ethanol | multiple interactions | EXP | | 6480464 | taraxerone promotes the reaction [Ethanol results in increased expression of ADH1 mRNA] | CTD | PMID:22554647 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of ADH1 mRNA | CTD | PMID:22554647 |
| ethanol | multiple interactions | ISO | RGD:1344246 | 6480464 | Pentachlorophenol inhibits the reaction [ADH1C protein results in increased metabolism of Ethanol] | CTD | PMID:19822198 |
| ethanol | increases metabolic processing | ISO | RGD:1344246 | 6480464 | ADH1C protein results in increased metabolism of Ethanol | CTD | PMID:15138216 PMID:19822198 |
| ethanol | increases metabolic processing | EXP | | 6480464 | ADH1 protein results in increased metabolism of Ethanol | CTD | PMID:7646056 PMID:7943667 |
| ethanol | multiple interactions | ISO | RGD:1344246 | 6480464 | fomepizole inhibits the reaction [ADH1C protein results in increased oxidation of Ethanol] | CTD | PMID:21167143 |
| ethanol | increases oxidation | ISO | RGD:1344246 | 6480464 | ADH1C protein results in increased oxidation of Ethanol | CTD | PMID:21167143 |
| ethanol | multiple interactions | ISO | RGD:1344246 | 6480464 | [ADH1C protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde | CTD | PMID:15138216 |
| ethanol | increases metabolic processing | ISO | RGD:1344246 | 6480464 | ADH1C protein results in increased metabolism of Ethanol | CTD | PMID:15138216 |
| ethanol | increases expression | ISO | RGD:2044 | 6480464 | Ethanol results in increased expression of ADH1 mRNA | CTD | PMID:15353170 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Zinc Sulfate] results in increased activity of ADH1 protein; more ... | CTD | PMID:15920153 |
| ethanol | multiple interactions | EXP | | 6480464 | [ADH1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde; more ... | CTD | PMID:7646056 |
| ethanol | increases metabolic processing | EXP | | 6480464 | ADH1 protein results in increased metabolism of Ethanol | CTD | PMID:7943667 PMID:7646056 |
| ethylene glycol | increases oxidation | ISO | RGD:1344246 | 6480464 | ADH1C protein results in increased oxidation of Ethylene Glycol | CTD | PMID:21167143 |
| fluconazole | decreases expression | ISO | RGD:2044 | 6480464 | Fluconazole results in decreased expression of ADH1 mRNA | CTD | PMID:16643972 |
| fomepizole | decreases activity | EXP | | 6480464 | fomepizole results in decreased activity of ADH1 protein | CTD | PMID:7943667 |
| fomepizole | multiple interactions | ISO | RGD:1344246 | 6480464 | fomepizole inhibits the reaction [ADH1C protein results in increased oxidation of Ethanol] | CTD | PMID:21167143 |
| formaldehyde | decreases response to substance | ISO | RGD:2044 | 6480464 | ADH1 protein results in decreased susceptibility to Formaldehyde | CTD | PMID:21276436 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADH1 mRNA | CTD | PMID:20003209 |
| methanol | increases oxidation | ISO | RGD:1344246 | 6480464 | ADH1C protein results in increased oxidation of Methanol | CTD | PMID:21167143 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2044 | 6480464 | Diethylnitrosamine results in increased expression of ADH1 mRNA | CTD | PMID:12807726 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2044 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADH1 mRNA | CTD | PMID:17602206 |
| nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ADH1 mRNA | CTD | PMID:12540486 |
| ochratoxin A | decreases expression | ISO | RGD:2044 | 6480464 | ochratoxin A results in decreased expression of ADH1 mRNA | CTD | PMID:12700408 |
| omeprazole | decreases expression | ISO | RGD:1344246 | 6480464 | Omeprazole results in decreased expression of ADH1C mRNA | CTD | PMID:12040753 |
| ouabain | affects expression | ISO | RGD:1344246 | 6480464 | Ouabain affects the expression of ADH1C protein | CTD | PMID:17268060 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ADH1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:1344246 | 6480464 | Acetaminophen results in decreased expression of ADH1C mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of ADH1 mRNA | CTD | PMID:17562736 |
| pentachlorophenol | multiple interactions | ISO | RGD:1344246 | 6480464 | Pentachlorophenol inhibits the reaction [ADH1C protein results in increased metabolism of Ethanol] | CTD | PMID:19822198 |
| perfluorooctane-1-sulfonic acid | affects expression | EXP | | 6480464 | perfluorooctane sulfonic acid affects the expression of ADH1 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | affects expression | EXP | | 6480464 | perfluorooctanoic acid affects the expression of ADH1 mRNA | CTD | PMID:19429403 |
| phenobarbital | decreases expression | ISO | RGD:1344246 | 6480464 | Phenobarbital results in decreased expression of ADH1 mRNA | CTD | PMID:19084549 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADH1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:2044 | 6480464 | pirinixic acid results in increased expression of ADH1 mRNA | CTD | PMID:22112501 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ADH1 mRNA | CTD | PMID:20813756 PMID:17426115 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ADH1 mRNA | CTD | PMID:17426115 PMID:20813756 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2044 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ADH1 mRNA | CTD | PMID:19162173 |
| propan-2-ol | increases oxidation | ISO | RGD:1344246 | 6480464 | ADH1C protein results in increased oxidation of 2-Propanol | CTD | PMID:21167143 |
| raloxifene | increases expression | ISO | RGD:2044 | 6480464 | Raloxifene results in increased expression of ADH1 mRNA | CTD | PMID:15576828 |
| rifampicin | increases expression | ISO | RGD:1344246 | 6480464 | Rifampin results in increased expression of ADH1C mRNA | CTD | PMID:12040753 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of ADH1 mRNA | CTD | PMID:17555576 |
| testosterone | multiple interactions | ISO | RGD:2044 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of ADH1 mRNA] | CTD | PMID:20032058 |
| trimellitic anhydride | decreases expression | EXP | | 6480464 | trimellitic anhydride results in decreased expression of ADH1 mRNA | CTD | PMID:19042947 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ADH1 mRNA | CTD | PMID:17292431 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Ethanol] results in increased expression of ADH1 mRNA | CTD | PMID:19637192 |
| zinc atom | decreases expression | ISO | RGD:2044 | 6480464 | Zinc deficiency results in decreased expression of ADH1C mRNA | CTD | PMID:12672911 |
| zinc sulfate | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Zinc Sulfate] results in increased activity of ADH1 protein; more ... | CTD | PMID:15920153 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Ethanol] results in increased expression of ADH1 mRNA | CTD | PMID:19637192 |
| zinc(0) | decreases expression | ISO | RGD:2044 | 6480464 | Zinc deficiency results in decreased expression of ADH1C mRNA | CTD | PMID:12672911 |